Shared on08 Aug 25
OrthoPediatrics' valuation outlook is stable, with both the future P/E and net profit margin essentially unchanged, resulting in the consensus analyst price target holding steady at $33.86. What's in the News Expanded the OrthoPediatrics Specialty Bracing division with new clinics in California, Ohio, Colorado, New York, and internationally into Ireland, enhancing presence in key hospitals and entering new markets.
Shared on24 Apr 25Fair value Increased 4.01%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 2.95%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 0.73%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 5.08%
AnalystConsensusTarget has decreased shares outstanding growth rate from 0.0% to 0.0%.